Rejection of vaccination against the COVID-19 virus will increase morbidity and mortality

Mohammadreza Rezaeipour
{"title":"Rejection of vaccination against the COVID-19 virus will increase morbidity and mortality","authors":"Mohammadreza Rezaeipour","doi":"10.55124/ijde.v1i1.134","DOIUrl":null,"url":null,"abstract":"It has been about two years since the first COVID-19 epidemic began,now it coincides with the fifth peak of epidemic infection in some countries. Over the years we have experienced many ups and downs of this virus(1, 2).\nIt has been about two years since the first COVID-19 epidemic began,now it coincides with the fifth peak of epidemic infection in some countries. Over the years we have experienced many ups and downs of this virus(1, 2). Some people are still with us, but unfortunately, some have left us in the middle of their lives, and they have become victims of the COVID-19 pandemic(3). A virus that when it got into the world of people, many said: \"It does not last long and when it reaching warm seasons of the year, it will die prematurely and does not survive.\" However, the virus has survived to this today.\nEfforts have been made around the world to shine the bright rays of hope and life in the shady cornerscreated by it(4, 5). One of these constructive efforts is to obtain a vaccine against COVID-19.  COVID-19 vaccination rates have still not been optimal in some countries(6, 7). While China, India, and the United States have had the highest vaccination rates (over 100%) since August 4, 2021, the statistics are disappointing in some other countries(8). For example, approximately 1.16% of Iranians received vaccinations at the same time(6-8). This is not sufficient to achieve so-called herd immunity, and hospitals have become more crowded due to the serious spread of the more contagious type of delta.\nIn addition to the lack of appropriate vaccines due to economic sanctions following the political tensions in some countries,such as Iran(9, 10), the reasons for refusing free injections and neglecting preventive measures are also\ndifferent(5). The covid-19 virus survived and mutant and increased mortality. However, still, some people don't hear and look at these facts. The efforts of medical staff across the globe have not yet been properly heard(5). What remains are the challenges that have endangered human life on earth, and we seem to be counting it down. These barriers must be identified in a short time. The workload of medical staff has grown significantly. In addition, journalists and the press have come to their aid, reporting and promoting the views of professors, experts, and heads of the health care system in the press, and enlightenment efforts have reached the point where politicians are talking about COVID-19 in election campaigns(11). Although an unknown and difficult path has been taken so far, it seems that this path is still ahead(7). In addition to government agencies, removing these barriers requires residents' campaigns to get vaccinated for their health, for their grandparents, for their neighbors, or to use free incentives(5, 12).\nFailure to do so will result in significant health costs for governments and economies.Failure to get COVID-19 vaccination in most cases leads to hospitalization and usually leads to large bills. These expenses will be higher for the uninsured person. It also enhances the likelihood of re-globalization pandemic with its mutant strains(13).\nReferences:\n\nFerrer, R COVID-19 Pandemic: the greatest challenge in the history of critical care. Medicina intensiva. 2020;44(6):323.\nHe, J.; Chen, G.; Jiang, Y.; Jin, R.; Shortridge, A.; Agusti, S et al. Comparative infection modeling and control of COVID-19 transmission patterns in China, South Korea, Italy and Iran. Science of the Total Environment. 2020;747:141447.\nStock, AD.; Bader, ER.; Cezayirli, P.; Inocencio, J.; Chalmers SA, Yassari R, et al. COVID-19 infection among healthcare workers: serological findings supporting routine testing. Frontiers in medicine. 2020;7:471.\nRezaeipour, M COVID-19-Related Weight Gain in School-Aged Children. International Journal of Endocrinology and Metabolism. 2021;19(1).\nLazarus, JV.; Ratzan, SC.; Palayew, A.; Gostin, LO.; Larson, HJ.; Rabin, K et al. A global survey of potential acceptance of a COVID-19 vaccine. Nature medicine. 2021;27(2):225-8.\nBasiri N, Koushki M. Study of Vaccine Production Abroad and Scientific and Research Challenges of COVID-19 Vaccine Production in Iran. Annals of the Romanian Society for Cell Biology. 2021:17249-56.\n\n         7.Maserat, E.; Keikha, L.; Davoodi, S.; Mohammadzadeh, Z. E-health roadmap for COVID-            19 vaccine coverage in Iran. BMC Public Health. 2021;21(1):1-11.\n\nMathieu, E.; Ritchie, H.; Ortiz-Ospina, E.; Roser, M.; Hasell, J.; Appel, C et al. A global database of COVID-19 vaccinations. Nature human behaviour. 2021:1-7.\nRustamovich, KM The Impact of Economic Sanctions on Well-being of Vulnerable Populations of Target Countries. International Journal on Economics, Finance and Sustainable Development. 2019;1(1):17-20.\nSetayesh, S.; Mackey, TK.; Addressing the impact of economic sanctions on Iranian drug shortages in the joint comprehensive plan of action: promoting access to medicines and health diplomacy. Globalization and health. 2016;12(1):1-14.\nAten, M.; Transnational Kleptocracy and the COVID-19 Pandemic How to Contain the Spread? Transnational Kleptocracy and the COVID-19 Pandemic Containing the Spread. 2021:4.\n\n\nPaul, E.; Steptoe, A.; Fancourt, D.; Attitudes towards vaccines and intention to vaccinate against COVID-19: Implications for public health communications. The Lancet Regional Health-Europe. 2021;1:100012.\nDesapriya, E.; Parisa, K.; Gunatunge, K. RE: Global deaths from COVID-19 have surpassed 3 million in mid of April, 2021. 2021.\n","PeriodicalId":163207,"journal":{"name":"International Journal of Endocrinology: Diabetes and Metabolism","volume":"145 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Endocrinology: Diabetes and Metabolism","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.55124/ijde.v1i1.134","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

It has been about two years since the first COVID-19 epidemic began,now it coincides with the fifth peak of epidemic infection in some countries. Over the years we have experienced many ups and downs of this virus(1, 2). It has been about two years since the first COVID-19 epidemic began,now it coincides with the fifth peak of epidemic infection in some countries. Over the years we have experienced many ups and downs of this virus(1, 2). Some people are still with us, but unfortunately, some have left us in the middle of their lives, and they have become victims of the COVID-19 pandemic(3). A virus that when it got into the world of people, many said: "It does not last long and when it reaching warm seasons of the year, it will die prematurely and does not survive." However, the virus has survived to this today. Efforts have been made around the world to shine the bright rays of hope and life in the shady cornerscreated by it(4, 5). One of these constructive efforts is to obtain a vaccine against COVID-19.  COVID-19 vaccination rates have still not been optimal in some countries(6, 7). While China, India, and the United States have had the highest vaccination rates (over 100%) since August 4, 2021, the statistics are disappointing in some other countries(8). For example, approximately 1.16% of Iranians received vaccinations at the same time(6-8). This is not sufficient to achieve so-called herd immunity, and hospitals have become more crowded due to the serious spread of the more contagious type of delta. In addition to the lack of appropriate vaccines due to economic sanctions following the political tensions in some countries,such as Iran(9, 10), the reasons for refusing free injections and neglecting preventive measures are also different(5). The covid-19 virus survived and mutant and increased mortality. However, still, some people don't hear and look at these facts. The efforts of medical staff across the globe have not yet been properly heard(5). What remains are the challenges that have endangered human life on earth, and we seem to be counting it down. These barriers must be identified in a short time. The workload of medical staff has grown significantly. In addition, journalists and the press have come to their aid, reporting and promoting the views of professors, experts, and heads of the health care system in the press, and enlightenment efforts have reached the point where politicians are talking about COVID-19 in election campaigns(11). Although an unknown and difficult path has been taken so far, it seems that this path is still ahead(7). In addition to government agencies, removing these barriers requires residents' campaigns to get vaccinated for their health, for their grandparents, for their neighbors, or to use free incentives(5, 12). Failure to do so will result in significant health costs for governments and economies.Failure to get COVID-19 vaccination in most cases leads to hospitalization and usually leads to large bills. These expenses will be higher for the uninsured person. It also enhances the likelihood of re-globalization pandemic with its mutant strains(13). References: Ferrer, R COVID-19 Pandemic: the greatest challenge in the history of critical care. Medicina intensiva. 2020;44(6):323. He, J.; Chen, G.; Jiang, Y.; Jin, R.; Shortridge, A.; Agusti, S et al. Comparative infection modeling and control of COVID-19 transmission patterns in China, South Korea, Italy and Iran. Science of the Total Environment. 2020;747:141447. Stock, AD.; Bader, ER.; Cezayirli, P.; Inocencio, J.; Chalmers SA, Yassari R, et al. COVID-19 infection among healthcare workers: serological findings supporting routine testing. Frontiers in medicine. 2020;7:471. Rezaeipour, M COVID-19-Related Weight Gain in School-Aged Children. International Journal of Endocrinology and Metabolism. 2021;19(1). Lazarus, JV.; Ratzan, SC.; Palayew, A.; Gostin, LO.; Larson, HJ.; Rabin, K et al. A global survey of potential acceptance of a COVID-19 vaccine. Nature medicine. 2021;27(2):225-8. Basiri N, Koushki M. Study of Vaccine Production Abroad and Scientific and Research Challenges of COVID-19 Vaccine Production in Iran. Annals of the Romanian Society for Cell Biology. 2021:17249-56.          7.Maserat, E.; Keikha, L.; Davoodi, S.; Mohammadzadeh, Z. E-health roadmap for COVID-            19 vaccine coverage in Iran. BMC Public Health. 2021;21(1):1-11. Mathieu, E.; Ritchie, H.; Ortiz-Ospina, E.; Roser, M.; Hasell, J.; Appel, C et al. A global database of COVID-19 vaccinations. Nature human behaviour. 2021:1-7. Rustamovich, KM The Impact of Economic Sanctions on Well-being of Vulnerable Populations of Target Countries. International Journal on Economics, Finance and Sustainable Development. 2019;1(1):17-20. Setayesh, S.; Mackey, TK.; Addressing the impact of economic sanctions on Iranian drug shortages in the joint comprehensive plan of action: promoting access to medicines and health diplomacy. Globalization and health. 2016;12(1):1-14. Aten, M.; Transnational Kleptocracy and the COVID-19 Pandemic How to Contain the Spread? Transnational Kleptocracy and the COVID-19 Pandemic Containing the Spread. 2021:4. Paul, E.; Steptoe, A.; Fancourt, D.; Attitudes towards vaccines and intention to vaccinate against COVID-19: Implications for public health communications. The Lancet Regional Health-Europe. 2021;1:100012. Desapriya, E.; Parisa, K.; Gunatunge, K. RE: Global deaths from COVID-19 have surpassed 3 million in mid of April, 2021. 2021.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
拒绝接种COVID-19病毒疫苗将增加发病率和死亡率
自第一次COVID-19疫情开始以来,已经过去了大约两年,现在恰逢一些国家的第五个流行病感染高峰。多年来,我们经历了这种病毒的多次起伏(1,2),第一次COVID-19流行已经过去两年左右,现在恰逢一些国家的第五个流行感染高峰。多年来,我们经历了这种病毒的许多起起伏伏(1,2)。有些人仍然和我们在一起,但不幸的是,有些人在生命的中途离开了我们,他们成为了COVID-19大流行的受害者(3)。当这种病毒进入人类世界时,许多人说:“它不会持续很长时间,当它到达一年中的温暖季节时,它会过早死亡,无法存活。”然而,病毒已经存活到今天。世界各地都在努力让希望和生命的光芒照亮它所创造的阴暗角落(4,5)。这些建设性的努力之一就是获得新冠病毒疫苗。一些国家的COVID-19疫苗接种率仍未达到最佳水平(6,7)。尽管中国、印度和美国自2021年8月4日以来的疫苗接种率最高(超过100%),但其他一些国家的统计数据令人失望(8)。例如,大约1.16%的伊朗人同时接种了疫苗(6-8)。这不足以实现所谓的群体免疫,而且由于传染性更强的三角洲病毒的严重传播,医院变得更加拥挤。除了一些国家(如伊朗)在政治紧张局势之后由于经济制裁而缺乏适当的疫苗(9,10)之外,拒绝免费注射和忽视预防措施的原因也各不相同(5)。covid-19病毒存活并变异,死亡率上升。然而,仍然有一些人没有听到和看到这些事实。全球医务人员的努力尚未得到适当的倾听(5)。剩下的是威胁地球上人类生命的挑战,我们似乎正在倒计时。必须在短时间内确定这些障碍。医务人员的工作量大大增加。此外,记者和媒体也提供了帮助,在媒体上报道和宣传教授、专家和保健系统负责人的观点,政治家们在竞选活动中谈论COVID-19的启蒙努力也达到了这样的程度(11)。尽管到目前为止,我们已经走了一条未知而艰难的道路,但似乎这条道路仍在前方(7)。除政府机构外,消除这些障碍还需要居民为自己的健康、祖父母、邻居接种疫苗,或使用免费奖励措施(5,12)。如果不这样做,将给政府和经济体带来巨大的卫生成本。在大多数情况下,未能接种COVID-19疫苗会导致住院,通常会导致大笔账单。对于没有保险的人,这些费用会更高。它还增加了其突变株再次全球化大流行的可能性(13)。参考文献:Ferrer, R COVID-19大流行:重症监护史上最大的挑战。药物intensiva。2020年,44(6):323。他,j .;陈,g;江,y;金,r;Shortridge, a;Agusti, S等。中国、韩国、意大利和伊朗COVID-19传播模式的比较感染模型和控制环境科学。2020;47:141447。股票,广告。巴德,呃。Cezayirli p;Inocencio, j .;Chalmers SA, Yassari R,等。卫生保健工作者中COVID-19感染:支持常规检测的血清学结果医学前沿。2020; 7:471。与2019冠状病毒病相关的学龄儿童体重增加。国际内分泌与代谢杂志,2021;19(1)。拉撒路,合资企业。Ratzan, SC。Palayew, a;Gostin瞧。拉森,HJ。;拉宾、凯等人。对COVID-19疫苗潜在接受度的全球调查。自然医学。2021; 27(2): 225 - 8。王晓明,王晓明。国外疫苗生产现状及伊朗新冠肺炎疫苗生产面临的科研挑战。细胞生物学学报,2011:1749 -56。7.Maserat大肠;Keikha l;•美国;Mohammadzadeh, Z.伊朗COVID- 19疫苗覆盖的电子卫生路线图。中华医学会公共卫生杂志,2011;21(1):1-11。马修,大肠;里奇,h;Ortiz-Ospina大肠;拱形门,m;Hasell, j .;阿佩尔,C等人。全球COVID-19疫苗接种数据库。自然,人类行为。2021:1-7。经济制裁对目标国家弱势群体福祉的影响。国际经济金融与可持续发展,2019;1(1):17-20。Setayesh,美国;麦基,TK。在《联合综合行动计划》中处理经济制裁对伊朗药品短缺的影响:促进获得药品和卫生外交。全球化和健康。2016; 12(1): 1 - 14。 阿托恩,m;跨国盗贼统治与COVID-19大流行如何遏制传播?跨国盗贼统治与遏制新冠肺炎疫情的传播。20121:4。保罗,大肠;斯特普托,a;Fancourt d;对疫苗的态度和接种COVID-19疫苗的意向:对公共卫生传播的影响。《柳叶刀-欧洲区域卫生》。2021; 1:100012。Desapriya大肠;Parisa k;截至2021年4月中旬,全球COVID-19死亡人数已超过300万。2021.
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Body Fat Removal Rejection of vaccination against the COVID-19 virus will increase morbidity and mortality Natural Competence for Transformation in Lactobacili Expression in situ of the recombinant human erythropoetin and recombinant insulin.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1